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Objective: Our objective was to study lung hyperacute rejection in the 
pig-to-human xenotransplantation combination. Methods: Pig lungs were 
harvested and continuously ventilated and perfused ex vivo, using a 
neonatal oxygenating system, with either xenogeneic unmodified human 
blood (n = 6) or autogeneic pig blood (n -- 6). Results: Autoperfused lungs 
displayed normal hemodynamics, oxygen extraction (arteriovenous oxygen 
difference), and histologic characteristics throughout he 3-hour study 
period. By contrast, xenoperfused lungs displayed, within 30 minutes, 
severe pulmonary hypertension and abolishment of arteriovenous oxygen 
difference culminating in massive pulmonary edema, hemorrhage, and lung 
failure after 115 - 44.2 minutes of reperfusion. Within 30 minutes, the 
human blood showed a significant drop of anti-o~Gal immunoglobulin M
and G xenoreactive antibodies (enzyme-linked immunosorbent assay) and 
complement activity, consumption of clotting factors, and hemolysis; total 
circulating human immunoglobulins remained substantially normal. His- 
tologically, lungs perfused with human blood were congestive and showed 
alveolar edema and hemorrhage and multiple fibrin and platelet thrombi 
obstructing the small pulmonary vessels (arterioles, capillaries, and 
venules) but not large (segmental or lobar) pulmonary vessels. On immu- 
nohistologic examination, deposits of human immunoglobulin M and 
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complement (Clq and C3) proteins were observed on the alveolar capillar- 
ies. Conclusions: This pig-to-human xenograft model suggests that the pig 
lung perfused with human blood has an early and violent hyperacute 
rejection that results in irreversible pulmonary dysfunction and failure 
within approximately 150 minutes of reperfusion. (J Thorac Cardiovasc 
Surg 1997;114:315-25) 
T he ongoing shortage of human organs for allo- transplantation, coupled with scientific 1and bio- 
technologic 2 advances, has catalyzed new attempts 
to use animal organs in human beings, a field known 
as xenotransplantation. The source of such animals 
is, however, controversial. Although nonhuman pri- 
mates, like chimpanzees and baboons, offer the 
advantages of phylogenic proximity (concordant xe- 
notransplants), they are unlikely to bridge the organ 
gap because they are limited in number and size, can 
harbor pathogens lethal to human beings, 3 and 
present ethical and social dilemmas that are difficult 
to overcome. 4 
Conversely, nonprimate donors, most notably 
pigs, are more likely to be favored because they are 
easily bred, physiologically similar, and accepted for 
human consumption. Their clinical application is, 
however, limited by hyperacute rejection (HAR). 
This reaction, observed when organs are engrafted 
between phylogenically distant species such as the 
pig-to-primate (discordant xenotransplants) combi- 
nation,4, 5 is triggered by binding of human xenore- 
active natural antibodies to endothelial xenograft cells 
with subsequent complement activation. It leads to 
irreversible xenograft damage and loss within minutes 
or 1 to 2 hours in untreated recipients. TM 
However, recent experimental 2' 12, 13 and clini- 
cal14, 15 cardiac xenotransptantation 16 studies have 
certainly shown that the seemingly insuperable bar- 
rier of HAR in the pig-to-primate model is crum- 
bling. I Unfortunately, similar advances in the do- 
main of lung xenotransplantation are yet not 
available.17, 18 This work was done to depict the 
HAR in the pig-to-human lung combination and the 
functional, immunologic, and histologic events con- 
tributing to its onset. 
Materials and methods 
Animals and study design. Outbred pigs of the race 
Large White weighing approximately 20to 30 kg served as 
lung donors. All animals received care in compliance with 
the "Principles of Laboratory Animal Care" formulated 
by the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
formulated by the National Academy of Sciences and 
published by the National Institutes of Health (NIH 
publication No. 85-23, revised 1985). Human blood was 
obtained from informed patients (Claude Huriet Law, No. 
88-1138, December 20, 1988) affected by hemochromato- 
sis undergoing therapeutic phlebotomies; blood units (two 
AB+, three O+, and one A+) were collected at the 
Blood Banks of the West Ile-de-France Public Interest 
Group (GIP) and screened for virally transmitted is- 
eases. Each blood unit (400 ml) was anticoagulated with 
1.2 units of heparin per milliliter and used within 30 days. 
Pig left lungs were harvested and then ex vivo perfused 
with pig blood for 30 minutes to stabilize the perfusion 
and ventilation system without he oxygenating system. A 
neonatal oxygenating system was then interposed in the 
perfusion circuit, and lungs were perfused either with 
autogeneic pig blood for a 3-hour study period (n = 6) or 
xenogeneic unmodified human blood until the onset of 
HAR (n = 6). To study the functional, immunologic, and 
coagulation effects of autogeneic and xenogeneic lung 
perfusion, we took blood samples at baseline and after 10, 
20, 30, 60, 90, 120, 150, and 180 minutes of reperfusion 
and plasma was subsequently stored in aliquots at -80 ° C 
until use. 
Harvest technique. Animals were premedicated with 
intramuscular ketamine hydrochloride (25 mg/kg) and 
atropine sulfate (1 mg/kg) and anesthetized with intrave- 
nous sodium pentobarbital (25 mg/kg). After orotracheal 
intubation, anesthesia was maintained with inhaled halo- 
thane and the animals' lungs were ventilated (Labaz Inc. 
Ventilator, Chemin Cami-Sali6, Pau, France) at an equal 
gas mixture of oxygen and protoxide. Ear venous catheters 
were placed for infusion of crystalloid solutions and 
adequacy of ventilation and oxygenation was assessed by 
arterial blood gas analysis and pulse oximetry. After 
completion of a median sternotomy and upper laparot- 
omy, the abdominal viscera were lifted away from the 
diaphragm to avoid compression of the lower lung lobes 
and the anterior pericardium was opened and suspended. 
After systemic heparinization (3 mg/kg), a 4-0 polypro- 
pylene (Prolene, Ethicon, Inc., Somerville, N.J.) purse- 
string stitch was placed on the anterior surface of the 
ascending aorta, and an aortic root cannula (DLP, Inc., 
Grand Rapids, Mich.) was inserted for collection of 
approximately 400 ml of autogeneic blood. The left lung 
was then harvested after topical electrically induced car- 
diac arrest. Care was taken to have the maximum length of 
the left pulmonary artery and main bronchus and a large 
cuff of left atrium incorporating the two left pulmonary 
veins and the venous return from the infracardiac lobe of 
the right lung. Once harvested, a 4-0 Prolene purse-string 
suture was placed on the free cuff walls of the left atrium. 
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Fig. 1. The isolated perfused and ventilated ex vivo lung model. Human blood (1) fills the oxygenator 
cardiotomy reservoir, where it is continuously deoxygenated (93% nitrogen, 5% carbon dioxide, and 2% 
oxygen) by the neonatal oxygenating system (2), enters through an arterial ine into the pulmonary artery, 
perfuses the lung, and returns to the cardiotomy reservoir through the venous line. A heater (3) warms the 
blood and lung to 37 ° C. This last, continuously ventilated by a mechanical ventilator (4) (75% nitrogen, 
20% oxygen, and 5% carbon dioxide gas mixture), is suspended in a humidified chamber (5). 
Then, the left lung was instrumented by placing a 3/8-inch 
straight ube connector (Dideco Inc., Mirandola, Italy) in 
the left pulmonary artery for pulmonary artery inflow, one 
in the left main bronchus for mechanical ventilation, and 
one in the cuff of the left atrium to passively drain 
pulmonary venous blood outflow. Ligatures were then tied 
around the cannulas. 
Ex vivo pig-to-human xenograft model. An ex vivo 
perfusion and ventilation model for the study of isolated, 
working pig lungs perfused with either autogeneic pig 
blood or xenogeneic human blood was developed as 
shown in Fig. 1. The left lungs were suspended by the left 
main bronchus connectors in a thermostated humidified 
chamber, continuously ventilated with room air (inspired 
oxygen fraction = 0.21) by a mechanical ventilator (Sie- 
mens-Elema, Solna, Sweden) through noncompressible 
tubing (tidal volume of 200 ml at 20 breaths/rain with 5 cm 
H20 positive end-expiratory pressure), and perfused with 
autogeneic undiluted pig blood for the first 30 minutes in 
both groups to obtain adequate stabilization. Hemolyza- 
tion of the residual pig blood was avoided by flushing the 
pigs' lungs with 0.5 L saline solution before reperfusion 
with human blood. Thereafter, lungs were continuously 
ventilated with a 75% nitrogen, 20% oxygen, and 5% 
carbon dioxide gas mixture and perfused through the 
inflow and outflow connectors attached to the blood- 
primed perfusion circuit through silicone tubing (Bentley 
ByPass 70 tubing; Baxter Healthcare Corp., Bentley Div., 
Irvine, Calif.), with care taken to avoid introduction of air. 
Venous blood return was collected through the outflow 
cannula by gravity into the oxygenator cardiotomy reser- 
voir, continuously deoxygenated (93% nitrogen, 5% car- 
bon dioxide, and 2% oxygen) with the use of a neonatal 
oxygenating system (Polystan Safe Micro, Copenhagen, 
Denmark), and returned to the left pulmonary artery 
through a roller pump (Ismatec mod, Bioblock, Stras- 
bourg, France) at a flow rate of 100 ml/min. The entire 
perfusion circuit was limited to an internal volume of 200 
ml of heparinized blood (0.15 ml/kg). A heater (HAAKE 
FK/F4391, Berlin, Germany) warmed the humidified 
chamber and blood to 37 ° C. An additional 200 ml of 
donor autogeneic or xenogeneic blood was maintained in 
reserve to replace circuit volume loss resulting from blood 
sampling. Perfusion pressure was continuously monitored 
with a pressure transducer (Gould Electronics BV, 
Bilthoven, The Netherlands) placed in series with the 
perfusion inflow line. The perfusion flow rate was manu- 
ally adjusted to maintain a constant perfusion pressure of 
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Fig. 2. Hemodynamics (pulmonary vascular resistance, 
PVR) at baseline (time 0) and at specific time intervals 
after perfusion f pig lungs with pig or human blood. Data 
are expressed as mean _+ standard eviation (error bars) of 
the experiments. The difference was statistically significant 
(p < 0.0001). During the time interval between -30 and 0 
minutes, the pig lungs were perfused with autogeneic 
blood to stabilize the perfusion system. 
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Fig. 3. Oxygen extraction (AVO2) of pig lungs at specific 
time intervals after perfusion of pig lungs with pig or human 
blood. Data are expressed as mean _+ standard deviation 
(error bars) of the experiments; hemoglobin concentrations 
to calculate the AVQ were normalized for the observed 
hematocrit value. The difference was statistically significant 
(p < 0.0001). First 30 minutes as in Fig. 1. 
Fig. 4. Histologic studies of pig lungs perfused with hu- 
man blood. A, Intraarteriolar thrombus (big arrow) of 
fibrin and platelet; the respiratory epithelium of a small 
bronchus is indicated by the small arrow. (Original mag- 
nification ×360.) 
10 mm Hg. During reperfusion, pH and Na +, K +, Mg 2+, 
and Ca 2÷ ions were monitored and eventually adjusted to 
maintain physiologic values. 
Functional measurements. Arterial and venous blood 
samples were collected for blood gas analysis (ABL3, 
Radiometer A/S, Copenhagen, Denmark) and hematocrit 
evaluation (Cellokrit, AB Lar Lyunberg, Stockholm, Swe- 
den). Blood electrolytes and pH adjustments were made 
as necessary during the study period to maintain physio- 
logic arterial blood pH (7.3 to 7.4). Arterial samples were 
taken from the left atrial outflow cannula and venous 
samples from blood directly exiting the oxygenator. The 
arteriovenous oxygen difference (AVO2) was calculated 
from the following formula: 
AVO2 (ml Oi l00 ml blood) = ([1.34 × Hb] × [Sart ]  ) 
- ([1.34 x Hb] x [Sven]" 
where S is the arterial (S~r0 or venous (Sven) oxygen 
saturation and Hb is hemoglobin concentration (grams 
per deciliter). 
The pulmonary vascular esistance (PVR) was calcu- 
lated from measurements of the blood flow with a flow 
probe (Statham SP2202, Biomedical Div., Oxnard, Calif.) 
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Fig. 4, eont'd. B, Venular thrombus of fibrin and platelets in an interalveolar septum. C, Diffuse capillary 
congestion and alveolar edema and hemorrhage. (Original magnifications ×180.) 
and the pulmonary artery pressure (PAP) (Kipp et Zonen 
BDl12, Gagny, France) and calculated as follows: 
PAP 
PVR - 
Blood flow 
where pulmonary vascular resistance was expressed in 
millimeters of mercury per milliliter per minute, pulmo- 
nary artery pressure in millimeters of mercury, and blood 
flow in milliliters per minute. 
Complement activity. A quantitative assay was used to 
detect complement activity of the human blood, (Kalle- 
stad Quantiplate, Sanofi Diagnostics Pasteur S.A., 
Marnes-la-Coquette, France). In brief, human serum is 
placed in wells and diffuses through an agarose gel 
medium containing standardized sheep erythrocytes sen- 
sitized with hemolysin. Total complement activity (CHloo) is 
subsequently estimated by comparing the extent of the lysis 
of the sheep erythrocytes caused by the human serum with 
that caused by a standard reference serum. By definition, 
one unit of complement (CHloo) at pH 7.4, 37 ° C in veronal 
buffer for 60 minutes will lyse 2 × 108 sheep erythrocytes 
sensitized with two units of hemolysin. Pathologic CHlo o 
values fall less than 70 CHlo o units per milliliter. 
Immunoglobulin levels, hemolysis, and coagulations in 
human blood. The levels of total circulating human im- 
munoglobulins (Ig) G, A, and M (grams per liter) were 
evaluated with the use of class-specific antibodies (Roche 
Diagnostics, Nevilly-sur-Seine, France) and measured by 
end-point turbidity at 340 nm. Lysis of red blood cells was 
determined by measuring the absorbance of a diluted 
plasma at 547 nm with reference to a standard curve of 
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Fig. 5. Wet/dry weight ratio of pig lungs perfused with 
pig (autogeneic) or human (xenogeneic) blood. Data are 
expressed as mean - standard eviation (error bars) of the 
experiments. The difference was statistically significant 
(p < 0.01). 
known hemoglobin values and expressed as milligrams of 
hemoglobin per 100 ml. Prothrombin time and activated 
partial thromboplastin time were measured on a fibrin 
timer 10-semiautomatic device (Behring, Rueil Malmai- 
son, France) by in vitro activation (37 ° C) of plasma with 
human placental thromboplastin (Thromborel S, 
Behring), and micronized silica (automated APTT, Or- 
ganon Teknika, Fresnes, France), respectively. Chrono- 
metric determination f fibrinogen level (grams per liter) 
19 was made according to the Clauss method, on ST 888 
semiautomatic device (Diagnostica-Stago, Asnieres, 
France) by in vitro activation (37 ° C) of plasma with 
bovine thrombin (Fibrinomat, BioMdrieux, Marcy- 
l'Estoule, France). The effects of heparin on the activated 
partial thromboplastin times were evaluated by the 
anti-Xa activity, which was kept less than 0.5 IU/ml. 
Measurement of natural aGal antibodies. The en- 
zyme-linked immunosorbent assay for isotype-specific de- 
tection of human natural xenoreactive antibodies to the 
aGal disaccharide pitope was performed as previously 
described by one of us. 2° Microtiter plates (NUNC maxi- 
sorp, NUNC AB, Roskilde, Denmark) were coated over- 
night at 4°C with synthetic Galcd-3Gal disaccharide 
coupled to polyacrylamide (PAA-Bdi, Syntesome, Mu- 
nich, Germany) in 0.1 mol/L carbonate buffer, pH 9.6. The 
plates were then washed with phosphate-buffered saline 
solution, pH 7.4, containing 0.02% Tween 20 (PBS- 
Tween). The sera were diluted 1:40 in phosphate-buffered 
saline solution, pH 7.4, containing 1% bovine serum 
albumin and 5% Tween (PBS-BSA-Tween) and incubated 
(100 /zl/well) for 2 hours at 37 ° C. After being washed, 
bound anti-aGal antibodies were detected by means of 
monoclonal antibodies to human IgG (clone HB43), IgM 
(clone HB57), or IgA (clone 4E8). These secondary 
monoclonal antibodies are mouse IgG1 and were in turn 
revealed by biotinylated goat antimouse IgG1 (SBA, 
Birmingham, Ala.), streptavidin-alkaline phosphatase 
conjugate (Amersham International, Amersham, United 
Kingdom), and 4-nitrophenyl-phosphate substrate. The 
optical density at 405 nm was measured with the use of a 
microplate reader. 
Histology. In each case, the whole left lung was mac- 
roscopically assessed regarding its edematous and hemor- 
rhagic appearance. At least four samples of representative 
areas including the hilum with large vessels, pleura, 
interlobular septa, and all abnormal lesions were taken. 
The tissues were inflated in 10% formaldehyde and rou- 
tinely processed into paraffin wax. Sections were cut at 5 
/xm and stained with hematoxylin and eosin. Sections from 
paraffin blocks were also used for immunohistochemical 
studies performed with the LSAB Kit (Dako SA, Trappes 
Cedex, France). Rabbit antibodies were used: antihuman 
IgM and IgG (both at 1:1000) and anti-C3 at 1 to 30 
(Biogenex-Menarini, Chevilly-Larue, Paris, France). 
Fresh tissue was also snap-frozen i liquid nitrogen and 
stored at -70 ° C. Immunostaining was carried out on 
cryostat sections by direct fluorescence. Fluorescein iso- 
thiocyanate-conjugated rabbit antibodies (Dako) were 
used diluted 1 to 10: antihuman IgM, Clq, C3, and 
antifibrinogen or anti-IgG were diluted 1 to 20. 
Wet/dry weight ratio. Wet lung weight was estimated by 
measuring the weight of the lungs at the beginning and at 
the end of the experiment. Lungs excised at the end of the 
experiments were dried in an oven at 60 ° C for 30 days and 
weighed again to allow determination of wet/dry weight 
ratio. 
Statistical analysis, All quantitative sera or plasma 
data measured at baseline and after the ex vivo reperfu- 
sion period were normalized for hemodilution by correct- 
ing them for changes in hematocrit value. Data are 
expressed as mean -+ standard eviation of the number of 
observations and analyzed by one-way analysis of variance 
(repeated measures) with Fisher's protected least signifi- 
cance difference. Data were analyzed by means of a 
software package (STATVIEW 4.02, Abacus Concepts, 
Inc., Berkeley, Calif.). The a priori level of significance 
was set at p < 0.05. 
Results 
Pulmonary function. In the lungs perfused with 
autologous pig blood, normal pulmonary vascular 
resistance and AVO 2 persisted for the entire 3- 
hour study period. Conversely, xenoperfused 
lungs never displayed normal function. Pulmonary 
vascular esistance rose profoundly in the first 30 
minutes of reperfusion, declined thereafter, and 
remained at values triple the ones observed in the 
autoperfused lungs (Fig. 2). Likewise, the AVO2 
was always below its physiologic values, with levels 
diminishing to zero or near zero by 48.3 +_ 26.3 
minutes of initiation of reperfusion (Fig. 3). Graft 
failure occurred in all lungs perfused with human 
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Fig. 6. A, Immunofluorescence with antihuman fibrinogen showing multiple thrombosis n the capillary 
lumen of the alveolar septa. A thrombus een longitudinally is indicate by the arrow. B, Immunofluores- 
cence with antihuman C3 showing diffuse deposition of the C3 protein along the alveolar capillaries. 
(Original magnifications ×200.) 
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Fig. 7. Total complement activity (CHloo) in human 
plasma at baseline (time 0) and at specific time intervals 
after xenogeneic perfusion of pig lungs with human blood. 
Data are expressed as mean _+ standard eviation (error 
bars) of the experiments and normalized for the observed 
hematocrit value. Values below the dotted line are patho- 
logic (< 70 CHao o units/ml). The CHaoo activity dropped 
from 274.4 -+ 43.2 to 47.7 _+ 6.4 units/ml over the study 
period (p < 0.0001). First 30 minutes as in Fig. 1. 
blood after 60 minutes (n = 2), 120 minutes (n = 
1), and 150 minutes (n = 3) (mean survival time, 
115 + 44.2 minutes) of reperfusion and was 
associated with no gas exchange, severe pulmo- 
nary hypertension, and gross evidence of pulmo- 
nary hemorrhagic edema. 
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Fig. 8. Hemolysis at baseline (time 0) and at specific time 
intervals after perfusion of pig lungs with pig or human 
blood. Data are expressed as mean _+ standard eviation 
(error bars) of the experiments and ormalized for the 
observed hematocrit value. The dotted line represents 
values normally observed uring human cardiopulmonary 
bypass procedures at our institution (<150 rag/100 ml). 
The difference was statistically significant (p < 0.0001). 
First 30 minutes as in Fig. 1. 
Histopathology and immunopathology. All au- 
toperfused lungs were macroscopically and histolog- 
ically intact. By contrast, xenoperfused lungs ap- 
peared macroscopically congestive, hemorrhagic, 
and mottled with red and yellows areas. Microscop- 
ically, the lungs perfused with human blood showed 
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Fig. 9. Hematocrit value at baseline (time 0) and at 
specific time intervals after perfusion of pig lungs with 
autogeneic oruntreated human blood. Data are expressed 
as mean _ standard eviation (error bars) of the experi- 
ments. The difference was statistically significant (p < 
0.0001). First 30 minutes as in Fig. 1. 
severe congestion, alveolar edema nd hemorrhage, 
and several fibrin and platelet hrombi localized in 
and obstructing small pulmonary vessels (arterioles, 
capillaries, and venules) but not large pulmonary 
vessels (segmental or lobar), a finding consistent 
with HAR (Fig. 4). No inflammatory cells were 
attached to the endothelial surfaces or infiltrating 
the lung parenchyma. The wet/dry weight ratio was 
4.1 _+ 0.3 in the lungs perfused with human blood 
and 2.55 _+ 0.2 in those perfused with autologous pig 
blood (Fig. 5). 
By immunohistologic examination, the lungs per- 
fused with human blood showed diffuse staining of 
Clq, C3, fibrinogen, and human IgM within the 
alveolar capillary (Fig. 6); we were unable to find 
positive IgG and IgA stainings. The autoperfused 
lungs were always negative for pig IgG, IgM, Clq, 
and C3. 
Immunologic functions. Xenogeneic blood showed 
a 69% reduction in total complement activity, as 
measured by CHt0o, after 20 minutes of reperfusion 
(Fig. 7). Hemolysis increased gradually over the 
study period and was significantly higher (p < 
0.0001) in the xenogeneic than autogeneic blood 
(Fig. 8). Similarly, the hematocrit level remained 
Table I. Changes of coagulation factors in the 
human blood used for ex vivo perfusion of pig lungs 
Lung perfusion PT APTT Fibrinogen 
time (min) (sec) (sec) (graiL) 
Basel ine 19.2 ± 6.1 35.5 ± 7,8 8.8 ± 1.6 
10 13.8 ± 4.3 56.3 ± 36.3 6.3 -+ 1.2 
20 13.1 ± 3.7 65.3 ± 36.3 6.8 ± 1.5 
30 12.3 __ 2.8 68.8 ± 33.5 6.5 ± 1.7 
60 12 ~+ 2.8 61.8 + 48.2 5.5 -+ 2 
90 11 ± 0,9 69.6 ± 26.1 5.7 -+ 1.4 
120 10,3 ~ 0.9 79 ± 28.6 5.6 ± 0.4 
150 11 ± 1.3 88.8 ± 26.8 4.7 _+ 0.5 
PT, Prothrombin time; APTT, activated partial thromboplastin time. 
Fibrinogen levels were normalized for the hematocrit value. Data are 
expressed as mean +- standard eviation. PT and fibrinogen levels were 
significantly reduced over the study period (p = 0.03 and p = 0.04, 
respectively); the prolongation of APTI" did not reach statistical signifi- 
cance (p = 0.08). 
stable in the autogeneic blood whereas it increased 
gradually, reaching values 1.5 times that of baseline 
levels, at the end of the xenogeneic experiments 
(Fig. 9). Xenogeneic blood showed a significant 
activation of the coagulation system, as demon- 
strated by reduction in prothrombin time (p = 0.03) 
and plasmatic fibrinogen (/9 = 0.04) and the twofold 
prolongation of the activated partial thromboplastin 
time (p = 0.08) (Table I). 
Human blood units had a substantial concentra- 
tion variability of the baseline levels of anti-oeGal 
IgM (614.7 _ 367.1), IgG (764.9 + 433.8), and IgA 
(2837.3 _+ 3190.5) xenoreactive natural antibodies; 
no anti-o~Gal antibodies were detectable in the pig 
blood. On reperfusion, a significant early (10 min- 
utes) drop was noted in human anti-c~Gal IgM 
(85%) and anti-o~Gal IgG (63%), and this diminu- 
tion became only slightly more pronounced over 
time; the decrease in anti-~Gal IgA was not signif- 
icant over time (Fig. 10). Despite this significant 
reduction of natural anti-c~Gal xenoantibodies, total 
human immunoglobulins remained relatively un- 
changed throughout the reperfusion time (Table II). 
Discussion 
We have developed an ex vivo system that allows 
the study of isolated, working, human blood-per- 
fused pig lung. Owing to the closed nature of this 
model by virtue of the continuously ventilated and 
perfused lungs, we were able to accurately depict 
and reproduce the HAR in a species combination 
with potential clinical relevance. The results demon- 
strate that on reperfusion of pig lungs with human 
blood, lung HAR and failure occur within 60 to 150 
minutes. This time span is longer than that observed 
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Table II. Changes of total immunoglobulin 
concentration i  the human blood used for ex vivo 
perfusion of pig lungs 
Lung 
per fusion IgG IgM IgA 
time (min ) (gm/L ) (graiL) (graiL) 
Basel ine 29.1 + 5.8 2.8 _+ 1 6.2 _+ 2.9 
10 22.5 -- 6.5 2 + 0.5 4.2 -+ 1.9 
20 22.3 _+ 6.8 2 + 0.5 4.4 +- 1.8 
30 21.5 -+ 8.9 2.1 + 0.6 4.6 -- 2.1 
60 18.9 -+ 10.6 2 -+ 0.6 4 + 2.4 
90 21.3 _+ 11.1 1.9 -- 0.8 4.6 -- 2.4 
120 18.1 _+ 9.9 2.1 _+ 0.8 4.1 _+ 2.1 
150 20.1 _+ 10.2 2.1 _+ 1.1 4.2 _+ 2.4 
Data are expressed as mean -+ standard eviation. Immunoglobulin (Ig) 
levels were normalized for hematocrit value. The changes in the total IgG, 
IgM, and IgA levels were not significant (p > 0.2) over the study period. 
when pig hearts are perfused with human blood, for 
example, 25.2 ___ 5.6 minutes, 11' 21 which could sug- 
gest that the heart may be less xenotolerant than the 
lung. However, pig lungs never showed normal 
oxygen extraction function after reperfusion with 
human blood, and early and long-lasting severe 
pulmonary hypertension developed. These abnor- 
malities were always observed within 30 minutes of 
xenogeneic reperfusion, probably as a consequence 
of the obstruction of the small pulmonary vessels 
(arterioles, capillaries, and venules) by fibrin and 
platelet hrombi. If this hypothesis is correct, our 
results provide evidence that the lung is as suscep- 
tible to HAR as the heart and kidney. These results 
challenge recent suggestions made in a pig-to-ba- 
boon xenotransplantation model by Kaplon and 
associates, 17 in which lung xenotransplants were 
found to be less susceptible to HAR. This discrep- 
ancy probably reflects the different species combi- 
nation used or the criteria used to define HAR. 
During the first 30 minutes after lung reperfusion 
with human blood, the most violent reactions in the 
human blood included a significant reduction of 
the human anti-c~Gal antibodies and complement 
activity. It is well established that the two primary 
immunologic factors determining susceptibility of 
xenogeneic pig organs to HAR by human beings 
are (1) the recognition of endothelial cell antigens 
expressed in the pig by xenoreactive natural anti- 
bodies in the circulation of the human recipient and 
(2) the incompatibility of complement regulatory 
proteins of the donor with the recipient's com- 
plement system. 8 About 1% of the total normal 
human immunoglobulins are anti-o~Gal natural an- 
tibodies directed against Galal,3Gal/31,4GlcNAc 
(aGal epitope). 22 The reason is that human beings, 
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Fig. 10. Plasma IgM, IgG, and IgA anti-aGal antibodies 
at baseline (time 0) and at specific time intervals after 
perfusion of pig lungs with untreated human blood. Data 
are expressed as mean 2 standard eviation (error bars) of 
the experiments and normalized for the observed hemat- 
ocrit. IgM (p = 0.003) and IgG (p = 0.03) anti-aGal 
natural antibodies decreased significantly over the study 
period, whereas IgA did not reach the threshold of 
significance (t7 = 0.08). However, the three human anti- 
bodies had a similar kinetic pattern over time, because 
their decrease was particularly important in the first 30 
minutes (p < 0.0001) and remained stable thereafter. First 
30 minutes as in Fig. 1. OD, Optical density. 
like apes and Old World monkeys, lack the a1,3- 
galactosyltransferase22, 23 necessary for the synthesis 
of the aGal epitope, which is, conversely, densely 
distributed along the vascular tree of pig heart, lung, 
liver, kidney, and pancreas. 24' 2s Interestingly, we 
observed a significant early reduction of the natural 
anti-c~Gal IgM and IgG but not IgA antibodies, and 
this is in line with previous observations demonstrat- 
ing that the anti-c~Gal IgM and, to a lessen extent, 
IgG antibodies bind the c~Gal epitope on the endo- 
thelial cells 5' 26, 27 and initiate the HAR of pig-to- 
human xenotransplants. This is indirectly con- 
firmed in this study, in which the anti-aGal IgM 
and IgG human blood concentration dropped 
significantly in the first 30 minutes after reperfu- 
sion whereas the amount of total circulating im- 
munoglobulins remained substantially unchanged. 
Moreover, human IgM deposits were found on the 
pig alveolar capillaries, where the o~Gal epitope is 
strongly expressed24; the lack of IgG and IgA 
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staining does not mean that they are not on the 
capillaries but rather that the immunofluores- 
cence technique was unable to detect them be- 
cause the severe alveolar-capillary membrane 
hemorrhage weakens the contrast between the 
staining and the background. 
Although differing from results reported by 
Kaplon and colleagues 17 of a pig-to-baboon ortho- 
topic lung transplantation model, in which no anti- 
body-mediated HAR was observed, our results sug- 
gest that natural anti-aGal IgM and IgG antibodies 
play a key role in inducing xenotransplant injury in 
the pig lung-to-human combination. Interestingly, 
the baseline levels of human xenoreactive antibodies 
varied substantially among individuals, and this is in 
line with the findings of Platt and coworkers. 28 
Probably, the different baseline blood concentra- 
tions of IgM and IgG anti-aGal natural antibodies 2s
or heterogeneous expression of pig antigens on 
donor organs 29 may account for the substantial 
diversity in survival time we observed. 
Development of HAR depends on activation of 
the complement system, as demonstrated by its 
prevention when xenograft recipients are treated 
with complement-inhibitor agents like cobra venom 
factor, complement receptor type I, or gamma glob- 
ulin.S, 21, 30 In this study, human blood circulating 
into pig lungs showed an almost 70% reduction in 
the CH100 and a remarkable hemolysis within 30 
minutes. These two features were, in principle, not 
related to the ex vivo circuit by itself, because 
hemolysis did not occur in pig lungs perfused with 
pig blood. The reduction of CH100 is most probably 
due to complement consumption because accumu- 
lation of C3 complement proteins was observed 
along the alveolar capillary walls. Thus it is not 
utopistic to postulate that after binding of xenore- 
active human IgM and IgG antibodies to the pig 
lungs harboring the o~Gal epitope, the complement 
pathway becomes activated, as observed in most 
pig-to-primate xenotransplants. 5' 31 This in turn trig- 
gers HAR by an increase of vascular permeability 
and activation of coagulation and, thus, alteration of 
the endothelial cell function. In favor of these 
mechanisms i  the constant hematocrit ncrease and 
onset of edema in xenogeneic but not autogeneic 
perfused lungs and the significant consumption of 
the clotting factors over time. Leukocyte infiltra- 
tions were absent, suggesting that cellular reactions 
are not at the origin of lung HAR; this is further 
confirmed by the fact that a similar time-related and 
violent HAR still develops in pig lungs perfused with 
human blood depleted of its leukocytes (data not 
shown). 
In conclusion, the results generated from our ex 
vivo pig-to-human xenotransplantation model dem- 
onstrate that pig lungs perfused with human blood 
have an early and violent HAR that results in the 
loss of gas exchange, severe pulmonary hyperten- 
sion, and, ultimately, xenograft failure. The fact that 
this model permits the analysis of several functional 
parameters i  particularly attractive, because it pro- 
vides a useful tool to investigate how to prevent lung 
HAR. 
We express our gratitude for the excellent echnical 
assistance of Chantal Verriest, Mich~le Galliard, R6mi 
Burel, Pascal Gusmini, Heg6sippe Langouste, Bruno Bau- 
det, Aline Perrin, Annette Rakoto-Salama, nd Sylvie 
Plant6. The photographic contribution of Michel Paing 
and Denis Petraz is acknowledged. Special thanks are 
directed to Drs. Guiard Jean, Poutiers Philippe, and Bap 
Charly for their help in supervising the human blood units. 
REFERENCES 
1. Fabre JW. Nudging xenotransplantation owards humans. 
Nature Meal 1995;1:403-4. 
2. Cozzi E, White DJG. The generation of transgenic pigs as 
potential organ donors for humans. Nature Med 1996;1: 
964-6. 
3. Chapman LE, Folks TM, Salomon DR, et al. Xenotransplan- 
tation and xenogeneic infections. N Engl J Med 1995;333: 
1498-501. 
4. Allan JS. Xenotransplantation at a crossroads: prevention 
versus progress. Nature Med 1996;1:18-21. 
5. Platt JL, Bach FH. The barriers to xenotransplantation. 
Transplantation 1991;52:937-47. 
6. Lawson JH, Platt JL. Molecular barriers to xenotransplanta- 
tion. Transplantation 1996;62:303-10. 
7. Platt JL, Fishel RJ, Matas AJ, Reif SA, Bolman RM, Bach 
FH. Immunopathology f hyperacute rejection i a swine-to- 
primate model. Transplantation 1991;52:214-20. 
8. Collins BH, Parker WR, Platt JL. Characterization ofporcine 
endothelial cell determinants recognized by human atural 
antibodies. Xenotransplantation 1994;1:36-46. 
9. Bach FH, Robson SC, Winkler H, et al. Barriers to xeno- 
transplantation. Nature Med 1995;1:869-73. 
10. Lin SS, Platt JL. Immunologic barriers to xenotransplanta- 
tion. J Heart Lung Transplant 1996;15:547-55. 
11. McCurry KR, Kooyman DL, Alvarado CG, et al. Human 
complement regulatory proteins protect swine-to-primate 
cardiac xenografts from humoral injury. Nature Med 1995;1: 
423-7. 
12. Kirk AD, Heinle JS, Mault JR, Sanfilippo F.Ex vivo charac- 
terization of human anti-porcine hyperacute cardiac rejec- 
tion. Transplantation 1993;56:785-93. 
13. Kroshus TJ, Dalmasso AP, Leventhal JR, John R, Matas AJ, 
Bolman RM II. Antibody removal by column immunoabsorp- 
tion prevents tissue injury in an ex vivo model of pig-to- 
human xenograft hyperacute r jection. J Surg Res 1995;59: 
43-50. 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 114, Number 3 
Macchiarini et al. 3 2 5 
14. Czaplicki J, Blonska B, Religa Z. The lack of hyperacute 
xenogeneic heart transplant rejection in a human. J Heart 
Lung Transplant 1992;11:393-6. 
15. Thomson C. Humanised pig hearts boost xenotransplanta- 
tion. Lancet 1995;346:766. 
16. Hoopes CW, Platt JL. Molecular strategies for clinical xeno- 
transplantation in cardiothoracic surgery. Semin Thorac Car- 
diovasc Surg 1996;8:156-74. 
17. Kaplon R J, Platt JL, Kwiatkowski PA, et al. Absence of 
hyperacute r jection in pig-to-primate orthotopic pulmonary 
xenografts. Transplantation 1995;59:410-6. 
18. Pierson RN, Kaspar-Konig W, Tew DN, et al. Profound 
pulmonary hypertension characteristic of pig lung rejection 
by blood is mediated by xenoreactive antibodies independent 
of complement. Transplant Proc 1995;27:274. 
19. Clauss A. Gerinnungsphysiologische schnellmethode zur 
bestimmung des fibrinogens. Acta Haematol 1957;17:237-46. 
20. Rieben R, van AUmen E, Korchagina EY, et al. Detection, 
immunoabsorption, and inhibition of cytotoxic activity of 
anti-aGal antibodies using newly developed substances with 
synthetic Galal-3Gal disaccharide epitopes. Xenotransplan- 
tation 1995;2:98-106. 
21. Kroshus TJ, Rollins SA, Dalmasso AP, et al. Complement 
inhibition with an anti-C5 monoclonal ntibody prevents acute 
cardiac tissue injury in an ex vivo model of pig-to-human 
xenotransplantation. Transplantation 1995;60:1194-202. 
22. Galili U, Clark MR, Shohet SB, Buehler J, Macher B. 
Evolutionary relationship between the natural anti-aGal 
antibody and the Galal, 3Gal epitope in primates. Proc Natl 
Acad Sci U S A 1987;84:136%75. 
23. Galili U, Shohet SB, Kobrin E, Stults CLM, Macher BA. 
Man, apes, and Old World monkeys differ from other 
mammals in the expression of aGalactosyl epitopes on 
nucleated cells. J Biol Chem 1988;263:17755-62. 
24. Oriol R, Ye Y, Koren E, Cooper DKC. Carbohydrate 
antigens of pig tissues reacting with human natural anti- 
bodies as potential targets for hyperacute rejection in 
pig-to-human organ transplantation. Transplantation 1993; 
56:1433-42. 
25. Cooper DKC, Koren E, Oriol R. Oligosaccharides and 
discordant xenotransplantation. Immunol Rev 1994;141:31- 
58. 
26. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IFC. 
Anti-pig IgM antibodies in human serum react predomi- 
nantly with Gala(1,3)Gal epitopes. Proc Natl Acad Sei U S A 
1993;90:11391-5. 
27. Platt JL, Vercellotti CM, Dalmasso AP, et al. Transplanta- 
tion of discordant xenografts: a review of progress. Immunol 
Today 1990;11:450-6. 
28. Platt JL, Geller RL, Lindman B J, et al. The role of natural 
antibodies in the activation of xenogeneic endothelial cells. 
Transplantation 1991;52:1037-43. 
29. Geller RL, Rubinstein P, Platt JL. Variation in expression 
of porcine xenogeneic antigens. Transplantation 1994;59: 
272-7. 
30. Leventhal JR, Dalmasso AP, Cromwell JW, et al. Prolonga- 
tion of cardiac xenograft by depletion of complement. Trans- 
plantation 1993;55:857-66. 
31. Dalmasso AP, Vercellotti GM, Fishel RJ, Bolman RM, Bach 
FH, Platt JL. Mechanism of complement activation in the 
hyperacute rejection of porcine organs transplanted into 
primate recipients. Am J Pathol 1992;140:1157-66. 
